Logo image of CADLR.OL

CADELER A/S (CADLR.OL) Stock Fundamental Analysis

OSL:CADLR - Oslo Bors ASA - DK0061412772 - Common Stock - Currency: NOK

60.3  +0.3 (+0.5%)

Fundamental Rating

4

Overall CADLR gets a fundamental rating of 4 out of 10. We evaluated CADLR against 39 industry peers in the Construction & Engineering industry. CADLR has a bad profitability rating. Also its financial health evaluation is rather negative. CADLR is growing strongly while it is still valued neutral. This is a good combination!


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

CADLR had negative earnings in the past year.
In multiple years CADLR reported negative net income over the last 5 years.
In multiple years CADLR reported negative operating cash flow during the last 5 years.
CADLR.OL Yearly Net Income VS EBIT VS OCF VS FCFCADLR.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 -100M -200M

1.2 Ratios

Looking at the Return On Assets, with a value of -0.61%, CADLR is doing worse than 86.84% of the companies in the same industry.
The Return On Equity of CADLR (-0.98%) is worse than 86.84% of its industry peers.
Industry RankSector Rank
ROA -0.61%
ROE -0.98%
ROIC N/A
ROA(3y)2.66%
ROA(5y)-4.28%
ROE(3y)3.35%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CADLR.OL Yearly ROA, ROE, ROICCADLR.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 50 100 150

1.3 Margins

CADLR's Profit Margin has improved in the last couple of years.
CADLR's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 31.70%, CADLR is doing worse than 71.05% of the companies in the same industry.
In the last couple of years the Gross Margin of CADLR has grown nicely.
CADLR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.7%
OM growth 3YN/A
OM growth 5Y38.97%
PM growth 3YN/A
PM growth 5Y52.64%
GM growth 3YN/A
GM growth 5Y40.93%
CADLR.OL Yearly Profit, Operating, Gross MarginsCADLR.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 -100 -150

More info and screens

3

2. Health

2.1 Basic Checks

CADLR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CADLR has been increased compared to 1 year ago.
CADLR has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CADLR has an improved debt to assets ratio.
CADLR.OL Yearly Shares OutstandingCADLR.OL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M
CADLR.OL Yearly Total Debt VS Total AssetsCADLR.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of 0.57, we must say that CADLR is in the distress zone and has some risk of bankruptcy.
CADLR's Altman-Z score of 0.57 is on the low side compared to the rest of the industry. CADLR is outperformed by 92.11% of its industry peers.
CADLR has a Debt/Equity ratio of 0.49. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of CADLR (0.49) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF N/A
Altman-Z 0.57
ROIC/WACCN/A
WACC5.73%
CADLR.OL Yearly LT Debt VS Equity VS FCFCADLR.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M 600M 800M

2.3 Liquidity

CADLR has a Current Ratio of 1.82. This is a normal value and indicates that CADLR is financially healthy and should not expect problems in meeting its short term obligations.
CADLR's Current ratio of 1.82 is amongst the best of the industry. CADLR outperforms 81.58% of its industry peers.
CADLR has a Quick Ratio of 1.81. This is a normal value and indicates that CADLR is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Quick ratio value of 1.81, CADLR belongs to the best of the industry, outperforming 89.47% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.82
Quick Ratio 1.81
CADLR.OL Yearly Current Assets VS Current LiabilitesCADLR.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M

More info and screens

7

3. Growth

3.1 Past

CADLR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -73.91%.
The Earnings Per Share has been growing by 47.94% on average over the past years. This is a very strong growth
CADLR shows a small growth in Revenue. In the last year, the Revenue has grown by 2.07%.
CADLR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.50% yearly.
EPS 1Y (TTM)-73.91%
EPS 3YN/A
EPS 5Y47.94%
EPS Q2Q%N/A
Revenue 1Y (TTM)2.07%
Revenue growth 3Y77.26%
Revenue growth 5Y8.5%
Sales Q2Q%N/A

3.2 Future

CADLR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 134.68% yearly.
The Revenue is expected to grow by 73.31% on average over the next years. This is a very strong growth
EPS Next Y213.11%
EPS Next 2Y224.45%
EPS Next 3Y181.91%
EPS Next 5Y134.68%
Revenue Next Year97.85%
Revenue Next 2Y100.76%
Revenue Next 3Y98.19%
Revenue Next 5Y73.31%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CADLR.OL Yearly Revenue VS EstimatesCADLR.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
CADLR.OL Yearly EPS VS EstimatesCADLR.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 1

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CADLR. In the last year negative earnings were reported.
CADLR is valuated reasonably with a Price/Forward Earnings ratio of 10.25.
CADLR's Price/Forward Earnings is on the same level as the industry average.
CADLR's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 92.74.
Industry RankSector Rank
PE N/A
Fwd PE 10.25
CADLR.OL Price Earnings VS Forward Price EarningsCADLR.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CADLR is valued a bit more expensive than 76.32% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 47.83
CADLR.OL Per share dataCADLR.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CADLR's earnings are expected to grow with 181.91% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y224.45%
EPS Next 3Y181.91%

More info and screens

0

5. Dividend

5.1 Amount

CADLR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CADELER A/S

OSL:CADLR (2/5/2025, 10:32:45 AM)

60.3

+0.3 (+0.5%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)11-26 2024-11-26/bmo
Earnings (Next)N/A N/A
Inst Owners32.01%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap5.29B
Analysts86
Price Target78.85 (30.76%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)12.37%
Min EPS beat(2)-6.79%
Max EPS beat(2)31.53%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.64%
Min Revenue beat(2)-4.69%
Max Revenue beat(2)-4.58%
Revenue beat(4)2
Avg Revenue beat(4)24.65%
Min Revenue beat(4)-4.69%
Max Revenue beat(4)80.27%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.15%
PT rev (3m)-0.04%
EPS NQ rev (1m)25%
EPS NQ rev (3m)12.9%
EPS NY rev (1m)15.9%
EPS NY rev (3m)31.02%
Revenue NQ rev (1m)7.38%
Revenue NQ rev (3m)6.78%
Revenue NY rev (1m)3.51%
Revenue NY rev (3m)3.06%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 10.25
P/S 2.03
P/FCF N/A
P/OCF N/A
P/B 0.4
P/tB 0.4
EV/EBITDA 47.83
EPS(TTM)-0.81
EYN/A
EPS(NY)5.89
Fwd EY9.76%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS29.77
BVpS151.37
TBVpS149.13
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.61%
ROE -0.98%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.7%
FCFM N/A
ROA(3y)2.66%
ROA(5y)-4.28%
ROE(3y)3.35%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)3.73%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y38.97%
PM growth 3YN/A
PM growth 5Y52.64%
GM growth 3YN/A
GM growth 5Y40.93%
F-ScoreN/A
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF N/A
Debt/EBITDA 28.1
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.82
Quick Ratio 1.81
Altman-Z 0.57
F-ScoreN/A
WACC5.73%
ROIC/WACCN/A
Cap/Depr(3y)757.66%
Cap/Depr(5y)785.56%
Cap/Sales(3y)180.33%
Cap/Sales(5y)370.92%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-73.91%
EPS 3YN/A
EPS 5Y47.94%
EPS Q2Q%N/A
EPS Next Y213.11%
EPS Next 2Y224.45%
EPS Next 3Y181.91%
EPS Next 5Y134.68%
Revenue 1Y (TTM)2.07%
Revenue growth 3Y77.26%
Revenue growth 5Y8.5%
Sales Q2Q%N/A
Revenue Next Year97.85%
Revenue Next 2Y100.76%
Revenue Next 3Y98.19%
Revenue Next 5Y73.31%
EBIT growth 1Y-53.97%
EBIT growth 3YN/A
EBIT growth 5Y50.78%
EBIT Next Year429.35%
EBIT Next 3Y197.32%
EBIT Next 5Y142.74%
FCF growth 1Y98.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y118.28%
OCF growth 3YN/A
OCF growth 5Y39.15%